{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T13:16:30Z","timestamp":1758460590629,"version":"3.44.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"am","delay-in-days":313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K01 AG066747"],"award-info":[{"award-number":["K01 AG066747"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.neuropharm.2023.109454","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T02:43:30Z","timestamp":1675392210000},"page":"109454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["L-type calcium channel antagonist isradipine age-dependently decreases plaque associated dystrophic neurites in 5XFAD mouse model"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0722-933X","authenticated-orcid":false,"given":"Jessica L.","family":"Wickline","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riley","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Odfalk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Javors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"Ginsburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5228-0022","authenticated-orcid":false,"given":"Sarah C.","family":"Hopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"volume":"18","first-page":"700","year":"2022","key":"10.1016\/j.neuropharm.2023.109454_bib1"},{"key":"10.1016\/j.neuropharm.2023.109454_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2010.08.020","article-title":"L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease","volume":"41","author":"Anekonda","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2023.109454_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1073\/pnas.90.2.567","article-title":"Alzheimer disease amyloid \u03b2 protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum","volume":"90","author":"Arispe","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2023.109454_bib4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2011.03.048","article-title":"Selective dihydropyiridine compounds facilitate the clearance of \u03b2-amyloid across the blood\u2013brain barrier","volume":"659","author":"Bachmeier","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109454_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s00424-009-0736-1","article-title":"Calcium hypothesis of Alzheimer's disease","author":"Berridge","year":"2010","journal-title":"Pflugers Arch. Eur. J. Physiol."},{"key":"10.1016\/j.neuropharm.2023.109454_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","article-title":"Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease","volume":"31","author":"Bezprozvanny","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109454_bib7","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1523\/JNEUROSCI.4814-07.2008","article-title":"Dynamics of the microglial\/amyloid interaction indicate a role in plaque maintenance","volume":"28","author":"Bolmont","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109454_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ceca.2012.12.003","article-title":"Microglial calcium signaling in the adult, aged and diseased brain","volume":"53","author":"Brawek","year":"2013","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neuropharm.2023.109454_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00401-013-1242-2","article-title":"Impairment of in vivo calcium signaling in amyloid plaque-associated microglia","volume":"127","author":"Brawek","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2023.109454_bib10","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1126\/science.1162844","article-title":"Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease","volume":"321","author":"Busche","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2023.109454_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00195912","article-title":"Influence of input rates on (+\/-)-isradipine haemodynamics and concentration-effect relationship in healthy volunteers","volume":"46","author":"Carrara","year":"1994","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109454_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a003947","article-title":"Voltage-gated calcium channels","volume":"3","author":"Catterall","year":"2011","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.neuropharm.2023.109454_bib13","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.1994.266.6.C1650","article-title":"K+ modulation of microglial superoxide production: involvement of voltage-gated Ca2+ channels","author":"Colton","year":"1994","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2023.109454_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7176","article-title":"Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b242 hotspots around plaques","volume":"6","author":"Condello","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2023.109454_bib15","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1242\/dmm.006841","article-title":"A translational continuum of model systems for evaluating treatment strategies in Alzheimer's disease: isradipine as a candidate drug","volume":"4","author":"Copenhaver","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.neuropharm.2023.109454_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000357383","article-title":"Short- and long-term treatment of mouse cortical primary astrocytes with \u03b2-amyloid differentially regulates the mRNA expression of L-type calcium channels","volume":"93","author":"Daschil","year":"2014","journal-title":"Pharmacology"},{"key":"10.1016\/j.neuropharm.2023.109454_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/exnr.1998.7010","article-title":"Neurochemical diversity of dystrophic neurites in the early and late stages of alzheimer's disease","volume":"156","author":"Dickson","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109454_bib18","first-page":"180","article-title":"Pharmacological and molecular enhancement of learning in aging and Alzheimer's disease","volume":"99","author":"Disterhoft","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2023.109454_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2014.12.004","article-title":"The L-type voltage-gated calcium channel modulates microglial pro-inflammatory activity","author":"Espinosa-Parrilla","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109454_bib20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neurobiolaging.2005.02.006","article-title":"Nimodipine selectively stimulates beta-amyloid 1-42 secretion by a mechanism independent of calcium influx blockage","volume":"27","author":"Facchinetti","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2023.109454_bib21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/gbb.12133","article-title":"Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics","volume":"13","author":"Flanigan","year":"2014","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2023.109454_bib22","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study","volume":"162","author":"Forette","year":"2002","journal-title":"Arch. Intern. Med."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109454_bib23","first-page":"1","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease","volume":"81","author":"Forner","year":"2021","journal-title":"Sci. Data"},{"key":"10.1016\/j.neuropharm.2023.109454_bib24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/syn.21915","article-title":"Calcium channel blockade attenuates abnormal synaptic transmission in the dentate gyrus elicited by entorhinal amyloidopathy","volume":"70","author":"Gholami Pourbadie","year":"2016","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2023.109454_bib25","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3233\/JAD-200109","article-title":"Electrophysiological and imaging calcium biomarkers of aging in male and female 5\u00d7FAD mice","volume":"78","author":"Ghoweri","year":"2020","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2023.109454_bib26","doi-asserted-by":"crossref","first-page":"E3699","DOI":"10.1073\/pnas.1510329112","article-title":"Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques","volume":"112","author":"Gowrishankar","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2023.109454_bib27","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1172\/JCI95898","article-title":"Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress","volume":"128","author":"Guzman","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2023.109454_bib28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuropharm.2023.109454_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0306-4522(00)00101-9","article-title":"\u03b2-Chemokines and human immunodeficiency virus type-1 proteins evoke intracellular calcium increases in human microglia","volume":"98","author":"Hegg","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2023.109454_bib30","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109454_bib31","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/01.wnl.0000345881.82856.d5","article-title":"Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons","volume":"72","author":"Hoffman","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2023.109454_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jnr.24585","article-title":"Targeting microglia L-type voltage-dependent calcium channels for the treatment of central nervous system disorders","volume":"99","author":"Hopp","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2023.109454_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-015-0262-3","article-title":"Calcium dysregulation via L-type voltage-dependent calcium channels and ryanodine receptors underlies memory deficits and synaptic dysfunction during chronic neuroinflammation","volume":"12","author":"Hopp","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109454_bib92","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.nbd.2011.04.007","article-title":"The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson\u2019s disease","volume":"43","author":"Ilijic","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2023.109454_bib34","doi-asserted-by":"crossref","first-page":"27916","DOI":"10.1074\/jbc.M602061200","article-title":"Acceleration of amyloid \u03b2-peptide aggregation by physiological concentrations of calcium","volume":"281","author":"Isaacs","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2023.109454_bib35","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1523\/JNEUROSCI.0617-19.2019","article-title":"Amyloid-beta modulates low-threshold activated voltage-gated L-type calcium channels of arcuate neuropeptide Y neurons leading to calcium dysregulation and hypothalamic dysfunction","volume":"39","author":"Ishii","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109454_bib36","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.neurobiolaging.2009.09.003","article-title":"Mechanisms underlying basal and learning-related intrinsic excitability in a mouse model of Alzheimer's disease","volume":"32","author":"Kaczorowski","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109454_bib37","first-page":"1","article-title":"CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease","volume":"31","author":"Kang","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2023.109454_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0197-4580(87)90073-X","article-title":"Hypothesis on the regulation of cytosol calcium concentration and the aging","volume":"8","author":"Khachaturian","year":"1987","journal-title":"Brain. Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2023.109454_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10059-011-0075-x","article-title":"Effects of amyloid-\u03b2 peptides on voltage-gated L-type CaV1.2 and CaV1.3 Ca2+ channels","volume":"32","author":"Kim","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2023.109454_bib40","doi-asserted-by":"crossref","first-page":"22100","DOI":"10.1074\/jbc.M101469200","article-title":"Alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages","volume":"276","author":"Koschak","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2023.109454_bib41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuron.2008.06.008","article-title":"A\u03b2 plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks","volume":"59","author":"Kuchibhotla","year":"2008","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109454_bib42","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrn960","article-title":"Calcium dyshomeostasis and intracellular signalling in alzheimer's disease","volume":"311","author":"LaFerla","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109454_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002660","article-title":"Nilvadipine in mild to moderate Alzheimer disease: a randomised controlled trial","volume":"15","author":"Lawlor","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.neuropharm.2023.109454_bib44","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41593-022-01084-8","article-title":"Faulty autolysosome acidification in Alzheimer's disease mouse models induces autophagic build-up of A\u03b2 in neurons, yielding senile plaques","volume":"25","author":"Lee","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109454_bib45","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1523\/JNEUROSCI.6412-10.2011","article-title":"Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an alzheimer\u2019s-like axonal dystrophy","volume":"31","author":"Lee","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109454_bib46","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.neubiorev.2006.03.006","article-title":"Habituation in rodents: a review of behavior, neurobiology, and genetics","volume":"30","author":"Leussis","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2023.109454_bib47","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.neuropharm.2008.10.016","article-title":"Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation","volume":"56","author":"Li","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109454_bib48","doi-asserted-by":"crossref","DOI":"10.1152\/jn.00486.2004","article-title":"L-type calcium channels: the low down","author":"Lipscombe","year":"2004","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2023.109454_bib49","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.18632\/aging.102951","article-title":"Verapamil extends lifespan in Caenorhabditis elegans by inhibiting calcineurin activity and promoting autophagy","volume":"12","author":"Liu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neuropharm.2023.109454_bib50","article-title":"Nimodipine for primary degenerative, mixed and vascular dementia","volume":"CD000147","author":"L\u00f3pez-Arrieta","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2023.109454_bib51","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1471-4159.2007.05135.x","article-title":"Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice","volume":"105","author":"Lopez","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2023.109454_bib52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1083\/jcb.201106120","article-title":"Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons","volume":"196","author":"Maday","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuropharm.2023.109454_bib53","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1042\/BST20130201","article-title":"Lysosome and calcium dysregulation in alzheimer's disease \u2013 partners in crime","volume":"41","author":"McBrayer","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2023.109454_bib54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00044011-199611040-00001","article-title":"Nimodipine in the treatment of probable alzheimer's disease: results of two multicentre trials","volume":"11","author":"Morich","year":"1996","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.neuropharm.2023.109454_bib55","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1371\/journal.pbio.0060026","article-title":"Partial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasis","volume":"6","author":"Mu","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2023.109454_bib56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.neuropharm.2023.109454_bib57","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109454_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.713726","article-title":"Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study","volume":"13","author":"Oblak","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109454_bib59","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2119\/molmed.2010.00180","article-title":"Selective antihypertensive dihydropyridines lower A\u03b2 accumulation by targeting both the production and the clearance of A\u03b2 across the blood-brain barrier","volume":"17","author":"Paris","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuropharm.2023.109454_bib60","first-page":"1","article-title":"Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers","volume":"51 5","author":"Park","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2023.109454_bib61","doi-asserted-by":"crossref","first-page":"39907","DOI":"10.1074\/jbc.M606015200","article-title":"Calcium-mediated transient phosphorylation of tau and amyloid precursor protein followed by intraneuronal amyloid-\u03b2 accumulation","volume":"281","author":"Pierrot","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2023.109454_bib62","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1046\/j.1471-4159.1997.69041580.x","article-title":"Caffeine stimulates amyloid \u03b2-peptide release from \u03b2-amyloid precursor protein-transfected HEK293 cells","volume":"69","author":"Querfurth","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2023.109454_bib63","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1021\/bi00181a016","article-title":"Calcium ionophore increases amyloid\/3 peptide production by cultured Cells1","volume":"33","author":"Querfurth","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2023.109454_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-01939-6","article-title":"Hippocampal interleukin-33 mediates neuroinflammation-induced cognitive impairments","volume":"17","author":"Reverchon","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2023.109454_bib65","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot5439","article-title":"Purification of RNA using TRIzol (TRI reagent)","author":"Rio","year":"2010","journal-title":"Cold Spring Harb. Protoc."},{"issue":"11","key":"10.1016\/j.neuropharm.2023.109454_bib66","first-page":"1","article-title":"Acitretin reverses early functional network degradation in a mouse model of familial Alzheimer's disease","volume":"111","author":"Rosales Jubal","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109454_bib67","first-page":"11","article-title":"Autophagy and its possible roles in nervous system diseases","volume":"1","author":"Rubinsztein","year":"2005","journal-title":"Damage and Repair"},{"key":"10.1016\/j.neuropharm.2023.109454_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263332","article-title":"Oral nimodipine treatment has no effect on amyloid pathology or neuritic dystrophy in the 5XFAD mouse model of amyloidosis","volume":"17","author":"Sadleir","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2023.109454_bib69","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1476-5381.2012.02112.x","article-title":"Nimodipine inhibits IL-1\u03b2 release stimulated by amyloid \u03b2 from microglia","volume":"167","author":"Sanz","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"24","key":"10.1016\/j.neuropharm.2023.109454_bib70","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41380-019-0396-2","article-title":"Sequential formation of different layers of dystrophic neurites in Alzheimer's brains","volume":"249","author":"Sharoar","year":"2019","journal-title":"Mol. Psychiatr."},{"issue":"10","key":"10.1016\/j.neuropharm.2023.109454_bib71","first-page":"1","article-title":"Felodipine induces autophagy in mouse brains with pharmacokinetics amenable to repurposing","volume":"101","author":"Siddiqi","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2023.109454_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-8993(98)01272-4","article-title":"Activation of microglial cells by PrP and \u03b2-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels","author":"Silei","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109454_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jnr.20093","article-title":"Microglia and Alzheimer's disease pathogenesis","volume":"77","author":"Streit","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2023.109454_bib74","doi-asserted-by":"crossref","first-page":"13300","DOI":"10.1021\/ja103725c","article-title":"Transmembrane structures for Alzheimer's A\u03b21-42 oligomers","volume":"132","author":"Strodel","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2023.109454_bib75","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/1073858407299730","article-title":"The pathogenesis of Alzheimers disease - is it a lifelong \u201ccalciumopathy\u201d","volume":"13","author":"Stutzmann","year":"2007","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2023.109454_bib76","article-title":"Improving preclinical to clinical translation in Alzheimer's disease research","volume":"6","author":"Sukoff Rizzo","year":"2020","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"author":"Thomas","key":"10.1016\/j.neuropharm.2023.109454_bib77"},{"key":"10.1016\/j.neuropharm.2023.109454_bib78","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0006-3223(90)90050-C","article-title":"Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia","volume":"27","author":"Tollefson","year":"1990","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109454_bib79","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00543970","article-title":"Pharmacokinetics of PN 200-110 (isradipine), a new calcium antagonist, after oral administration in man","volume":"32","author":"Tse","year":"1987","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109454_bib80","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.2042-7158.1989.tb06554.x","article-title":"Bioavailability of isradipine in young and old rats: effect of mode of administration","volume":"41","author":"Tse","year":"1989","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109454_bib81","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0024-3205(97)00881-3","article-title":"Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists","volume":"61","author":"Uchida","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2023.109454_bib82","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1101\/lm.34600","article-title":"Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat","volume":"7","author":"Vianna","year":"2000","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2023.109454_bib83","article-title":"Translational animal models for alzheimer's disease: an alzheimer's association business consortium think tank","volume":"6","author":"Vitek","year":"2020","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.neuropharm.2023.109454_bib84","article-title":"Blockade of microglial Cav1.2 Ca2+ channel exacerbates the symptoms in a Parkinson's disease model","volume":"9","author":"Wang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109454_bib85","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4103\/0366-6999.186646","article-title":"Amyloid \u03b2 protein aggravates neuronal senescence and cognitive deficits in 5XFAD mouse model of Alzheimer's disease","volume":"129","author":"Wei","year":"2016","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.neuropharm.2023.109454_bib86","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1471-4159.1994.62010372.x","article-title":"Rapid communication: Ca2+ channel blockers attenuate \u03b2-amyloid peptide toxicity to cortical neurons in culture","volume":"62","author":"Weiss","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2023.109454_bib87","doi-asserted-by":"crossref","first-page":"12137","DOI":"10.1523\/JNEUROSCI.0705-15.2015","article-title":"Neuronal-targeted TFEB accelerates lysosomal degradation of app, reducing A\u03b2 generation and amyloid plaque pathogenesis","volume":"35","author":"Xiao","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109454_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108169","article-title":"Limiting RyR2 open time prevents alzheimer's disease-related neuronal hyperactivity and memory loss but not \u03b2-amyloid accumulation","volume":"32","author":"Yao","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2023.109454_bib89","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2004.03.009","article-title":"Calcium channel blockers and risk of AD: the baltimore longitudinal study of aging","volume":"26","author":"Yasar","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2023.109454_bib90","first-page":"139","volume":"3","author":"Yue","year":"2006"},{"key":"10.1016\/j.neuropharm.2023.109454_bib91","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823000448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823000448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:22:27Z","timestamp":1758439347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823000448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":92,"alternative-id":["S0028390823000448"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109454","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L-type calcium channel antagonist isradipine age-dependently decreases plaque associated dystrophic neurites in 5XFAD mouse model","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109454"}}